The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Ki-67 protein as a tumour proliferation marker
Abstract
Newer treatment strategy based on proliferative nuclear marker Ki-67 targeted therapy holds promise for prioritized/personalized treatment options with regard to improved survival and outcome in patients with renal cancer. Over the past decade, the importance of Ki-67 in prognosis of breast cancer has been widely studied, however very few studies and literatures are available in the context of renal cancer which has an increasing incidence internationally. The focus of this present review is to fill the gaps pertaining to its prognosis and management with newly understood mechanisms of targeted interventions. Recent breakthrough discoveries have highlighted the correlation of Ki-67 expression to stage and metastatic potential in renal tumours. A better understanding of molecular structure and different protein domains along with its regulation will provide evidence for precise target thereby controlling the proliferation rate correlated with decrease in the Ki-67 protein levels. Therapies targeting Ki-67 is still in the preclinical stage, besides its diagnostic and/or prognostic significance, a better understanding of targeted strategical studies is required for extrapolation to the clinical use. Current understanding of the associated molecular pathways and the precise role of Ki-67 could streamline the basis for predicting renal cancer outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9212 · Cited by 1,402
Epidemiology and risk factors for kidney cancer
Chow, W.-H., Dong, L. M., & Devesa, S. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.46 · Cited by 1,384
King, R. W., Peters, J.-M., Tugendreich, S., Rolfe, M., Hieter, P., & Kirschner, M. W. (1995) · Cell · doi:10.1016/0092-8674(95)90338-0 · Cited by 955
Gerdes, J., Li, L., Schlueter, C. J., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., & Flad, H. D. (1991) · PubMed · Cited by 889
Proliferation Marker Ki-67 in Early Breast Cancer
Urruticoechea, A., Smith, I. E., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.501 · Cited by 837
Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
Satyanarayana, A., & Kaldis, P. (2009) · Oncogene · doi:10.1038/onc.2009.170 · Cited by 774
Schlüter, C., Duchrow, M., Wohlenberg, C., Becker, M. H., Key, G., Flad, H. D., & Gerdes, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.3.513 · Cited by 765
Common markers of proliferation
Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1802 · Cited by 650
Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
Cuylen, S., Blaukopf, C., Politi, A. Z., Müller-Reichert, T., Neumann, B., Poser, I., Ellenberg, J., Hyman, A. A., & Gerlich, D. W. (2016) · Nature · doi:10.1038/nature18610 · Cited by 562
Bruno, S., & Darzynkiewicz, Z. (1992) · Cell Proliferation · doi:10.1111/j.1365-2184.1992.tb01435.x · Cited by 375
Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels
Sobecki, M., Mrouj, K., Colinge, J., Gerbe, F., Jay, P., Krasinska, L., Dulic, V., & Fisher, D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0707 · Cited by 375
Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown
Taxman, D. J., Moore, C. B., Guthrie, E. H., & Huang, M. T.-H. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-657-3_10 · Cited by 365
The cell proliferation antigen Ki-67 organises heterochromatin
Sobecki, M., Mrouj, K., Camasses, A., Parisis, N., Nicolas, E., Llères, D., Gerbe, F., Prieto, S., Krasinska, L., David, A., et al. (2016) · eLife · doi:10.7554/elife.13722 · Cited by 362
Inhibition of human telomerase activity by peptide nucleic acids
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., & Corey, D. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-615 · Cited by 343
Cell cycle regulation of a Xenopus Wee1-like kinase.
Mueller, P. R., Coleman, T. R., & Dunphy, W. G. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.1.119 · Cited by 325
Petrelli, F., Viale, G., Cabiddu, M., & Barni, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3559-0 · Cited by 286
Antisense oligonucleotides in therapy for neurodegenerative disorders
Evers, M. M., Toonen, L. J. A., & van Roon-Mom, W. M. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.008 · Cited by 286
Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery
Booth, D. G., Takagi, M., Sanchez-Pulido, L., Petfalski, E., Vargiu, G., Samejima, K., Imamoto, N., Ponting, C. P., Tollervey, D., Earnshaw, W. C., et al. (2014) · eLife · doi:10.7554/elife.01641 · Cited by 224
Verheijen, R., Kuijpers, H. J. H., Schlingemann, R. O., Boehmer, A. L. M., Driel, R. V., Brakenhoff, G. J., & Ramaekers, F. C. S. (1989) · Journal of Cell Science · doi:10.1242/jcs.92.1.123 · Cited by 222
A review of the current status of siRNA nanomedicines in the treatment of cancer
Resnier, P., Montier, T., Mathieu, V., Benoit, J.-P., & Passirani, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.060 · Cited by 210
BUI, M. H. T., VISAPAA, H., SELIGSON, D., KIM, H., HAN, K.-R., HUANG, Y., HORVATH, S., STANBRIDGE, E. J., PALOTIE, A., FIGLIN, R. A., et al. (2004) · Journal of Urology · doi:10.1097/01.ju.0000116444.08690.e2 · Cited by 197
Kill, I. R. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1253 · Cited by 183
Dudderidge, T. J., Stoeber, K., Loddo, M., Atkinson, G., Fanshawe, T., Griffiths, D. F., & Williams, G. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1776 · Cited by 180
The Role of Hklp2 in the Stabilization and Maintenance of Spindle Bipolarity
Vanneste, D., Takagi, M., Imamoto, N., & Vernos, I. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.019 · Cited by 176
Chromophore‐assisted light inactivation of pKi‐67 leads to inhibition of ribosomal RNA synthesis
Rahmanzadeh, R., Hüttmann, G., Gerdes, J., & Scholzen, T. E. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00433.x · Cited by 153
He, X., Chen, Z., Fu, T., Jin, X., Yu, T., Liang, Y., Zhao, X., & Huang, L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-153 · Cited by 150
Time-lapse Imaging Reveals Dynamic Relocalization of PP1γ throughout the Mammalian Cell Cycle
Trinkle‐Mulcahy, L., Andrews, P. D., Wickramasinghe, S. R., Sleeman, J., Prescott, A. R., Lam, Y. W., Lyon, C. E., Swedlow, J. R., & Lamond, A. I. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0376 · Cited by 145
Ye, X. S., Xu, G., Pu, R. T., Fincher, R. R., McGuire, S. L., Osmani, A. H., & Osmani, S. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07079.x · Cited by 143
The chromosome periphery during mitosis
Hernandez‐Verdun, D., & Gautier, T. (1994) · BioEssays · doi:10.1002/bies.950160308 · Cited by 142
Rioux-Leclercq, N. C., Turlin, B., Bansard, J., Patard, J., Manunta, A. F., Moulinoux, J.-P., Guillé, F., Ramée, M. P., & Lobel, B. (2000) · Urology · doi:10.1016/s0090-4295(99)00550-6 · Cited by 129
Is the Ki-67 labelling index ready for clinical use?
Jonat, W., & Arnold, N. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq732 · Cited by 125
Scholzen, T. E., Endl, E., Wohlenberg, C., van der Sar, S., Cowell, I. G., Gerdes, J., & Singh, P. B. (2001) · The Journal of Pathology · doi:10.1002/path.1016 · Cited by 120
Development and evaluation of BioScore
Parker, A. S., Leibovich, B. C., Lohse, C. M., Sheinin, Y. M., Kuntz, S. M., Eckel‐Passow, J. E., Blute, M. L., & Kwon, E. D. (2009) · Cancer · doi:10.1002/cncr.24263 · Cited by 118
cdc25 is one of the MPM-2 antigens involved in the activation of maturation-promoting factor.
Kuang, J., Ashorn, C. L., Gonzalez-Kuyvenhoven, M., & Penkala, J. E. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.2.135 · Cited by 98
Endl, E., & Gerdes, J. (2000) · Journal of Cellular Physiology · Cited by 89
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer
Ali, H. R., Dawson, S., Blows, F. M., Provenzano, E., Leung, S. C. Y., Nielsen, T. O., Pharoah, P. D. P., & Caldas, C. (2011) · The Journal of Pathology · doi:10.1002/path.2976 · Cited by 83
Song, W. L., Zhou, W., Li, C., Hu, J., Hu, X., Chen, P., Shao, G., & Guo, W.-H. (2015) · BMC Cancer · doi:10.1186/s12885-015-1524-2 · Cited by 81
The Forkhead-associated Domain of Ki-67 Antigen Interacts with the Novel Kinesin-like Protein Hklp2
Sueishi, M., Takagi, M., & Yoneda, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003879200 · Cited by 74
Takagi, M., Sueishi, M., Saiwaki, T., Kametaka, A., & Yoneda, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102227200 · Cited by 74
Xie, Y., Chen, L., Ma, X., Li, H., Gu, L., Gao, Y., Yang, F., Zhang, Y., & Zhang, X. (2017) · Scientific Reports · doi:10.1038/srep44281 · Cited by 73
Gayed, B. A., Youssef, R. F., Bagrodia, A., Darwish, O. M., Kapur, P., Sagalowsky, A. I., Lotan, Y., & Margulis, V. (2013) · British Journal of Urology · doi:10.1111/bju.12263 · Cited by 60
Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies
Michael, A., & Pandha, H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01044-1 · Cited by 58
Takagi, M., Nishiyama, Y., Taguchi, A., & Imamoto, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556647 · Cited by 55
Li, H., Byeon, I. L., Ju, Y., & Tsai, M. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.032 · Cited by 54
Saiwaki, T., Kotera, I., Sasaki, M., Takagi, M., & Yoneda, Y. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.010 · Cited by 53
Takagi, M., Matsuoka, Y., Kurihara, T., et al. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.15.2463 · Cited by 51
The Prognostic Role of Ki-67/MIB-1 in Cervical Cancer: A Systematic Review with Meta-Analysis
Chen, G. (2015) · Medical Science Monitor · doi:10.12659/msm.892807 · Cited by 48
Zheng, J., Teng-xiang, M., Cao, J., Sun, X., Chen, J., Li, W., Wen, R.-M., Sun, Y., & Pei, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.064 · Cited by 46
Kankuri‐Tammilehto, M., Söderström, K., Pelliniemi, T., Vahlberg, T. J., Pyrhönen, S. O., & Salminen, E. K. (2006) · PubMed · Cited by 43
Cheutin, T., O’Donohue, M.-F., Beorchia, A., Klein, C., Kaplan, H., & Ploton, D. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305101102 · Cited by 35
A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression
Tian, H., Qian, G., Li, W., Chen, F., Di, J., Zhang, B., Pei, D., Ma, P., & Zheng, J. (2010) · Tumor Biology · doi:10.1007/s13277-010-0119-4 · Cited by 30
Antisense Oligonucleotide Therapy in Urology
Kausch, I., & Andreas Böhle, E. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64901-4 · Cited by 29
High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma
Luo, Y., Zhang, X., Mo, M., Tan, Z. T., Huang, L., Zhou, H., Wang, C., Wei, F., Qiu, X., He, R., et al. (2016) · Medicine · doi:10.1097/md.0000000000003337 · Cited by 29
MPM‐2 epitope sequence is not sufficient for recognition and phosphorylation by ME kinase‐H
Che, S., Weil, M. M., Nelman-Gonzalez, M. A., Ashorn, C. L., & Kuang, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00948-4 · Cited by 23
p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells
Wang, M., Pei, D., Qian, G., Yin, X., Cheng, Q., Li, L., Li, H., & Zheng, J. (2011) · Tumor Biology · doi:10.1007/s13277-011-0191-4 · Cited by 18
Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma
Orjuela, M. A., Orlow, I., Dudas, M. E., Ponce-Castañeda, M. V., Ridaura, C., Leal, C., Salazar, A., Abramson, D. H., Gerald, W. L., & Cordon‐Cardo, C. (2001) · Human Pathology · doi:10.1053/hupa.2001.24325 · Cited by 16
Wang, Z., Xie, H., Guo, L., Cai, Q., Shang, Z., Jiang, N., & Niu, Y. (2017) · Cancer Management and Research · doi:10.2147/cmar.s141670 · Cited by 10
Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells
Mesojednik, S., Kamenšek, U., & Čemažar, M. (2008) · Radiology and Oncology · doi:10.2478/v10019-008-0007-3 · Cited by 9
Cited by
Jiang, H., Yu, D., Yang, P., Guo, R., Kong, M., Gao, Y., Yu, X., Lu, X., & Fan, X. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.730 · Cited by 255
Zheng, H., Tang, Y., Zang, H., Luo, J., Zhou, H., Zhan, Y., Zou, Y., Wen, Q., Ma, J., & Fan, S. (2025) · Advanced Science · doi:10.1002/advs.202409416 · Cited by 7
Zang, S., Chen, J., Chevalier, C., Zhang, J., Li, S., Wang, H., Li, J., Chen, Y., Xu, H., Sheng, L., et al. (2024) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.16489 · Cited by 6
Metadata
- Authors
- Menon, S. S., Guruvayoorappan, C., Sakthivel, K. M., & Rasmi, R. R.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 491
- Pages
- 39-45
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2910326417
- Cited by
- 479
- References
- 60
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.